1.

U.S. regulators have approved whose aducanumab as the first treatment to attack a likely cause of Alzheimer's disease?

A. Amgen Inc
B. Pfizer Inc
C. Biogen Inc
D. Gilead Sciences Inc
E. Vertex Pharmaceuticals Inc
Answer» D. Gilead Sciences Inc


Discussion

No Comment Found